EGFR and small cell lung carcinoma: Related studies have found that EGFR-mutant NSCLC often presents an immunosuppressive phenotype, while most SCLC are also immunosuppressive with a lack of major histocompatibility complex-I (MHC-I) expression, and transformed SCLC also exhibit reduced MHC-I expression (28–30).